Abbott Laboratories (ABT)
118.60
+5.23
(+4.61%)
USD |
NYSE |
Nov 01, 16:00
119.14
+0.54
(+0.46%)
After-Hours: 20:00
Abbott Laboratories Gross Profit Margin (Quarterly): 55.83% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.83% |
| June 30, 2024 | 55.64% |
| March 31, 2024 | 55.21% |
| December 31, 2023 | 55.51% |
| September 30, 2023 | 54.60% |
| June 30, 2023 | 55.07% |
| March 31, 2023 | 55.57% |
| December 31, 2022 | 54.48% |
| September 30, 2022 | 55.53% |
| June 30, 2022 | 56.18% |
| March 31, 2022 | 58.07% |
| December 31, 2021 | 58.44% |
| September 30, 2021 | 59.53% |
| June 30, 2021 | 51.61% |
| March 31, 2021 | 57.91% |
| December 31, 2020 | 58.01% |
| September 30, 2020 | 55.20% |
| June 30, 2020 | 55.47% |
| March 31, 2020 | 57.53% |
| December 31, 2019 | 58.70% |
| September 30, 2019 | 58.42% |
| June 30, 2019 | 58.90% |
| March 31, 2019 | 58.06% |
| December 31, 2018 | 58.91% |
| September 30, 2018 | 58.65% |
| Date | Value |
|---|---|
| June 30, 2018 | 57.74% |
| March 31, 2018 | 58.50% |
| December 31, 2017 | 56.75% |
| September 30, 2017 | 57.89% |
| June 30, 2017 | 51.95% |
| March 31, 2017 | 51.67% |
| December 31, 2016 | 55.33% |
| September 30, 2016 | 56.90% |
| June 30, 2016 | 57.12% |
| March 31, 2016 | 56.19% |
| December 31, 2015 | 57.48% |
| September 30, 2015 | 56.47% |
| June 30, 2015 | 57.10% |
| March 31, 2015 | 57.50% |
| December 31, 2014 | 56.37% |
| September 30, 2014 | 54.34% |
| June 30, 2014 | 54.76% |
| March 31, 2014 | 52.18% |
| December 31, 2013 | 53.35% |
| September 30, 2013 | 53.26% |
| June 30, 2013 | 53.27% |
| March 31, 2013 | 54.78% |
| December 31, 2012 | 47.28% |
| September 30, 2012 | 52.73% |
| June 30, 2012 | 55.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
51.61%
Minimum
Jun 2021
59.53%
Maximum
Sep 2021
56.20%
Average
55.60%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.71% |
| Becton Dickinson & Co | 46.23% |
| ResMed Inc | 58.57% |
| Integra Lifesciences Holdings Corp | 54.02% |
| QuidelOrtho Corp | 43.33% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.78% |
| Return on Assets | 7.90% |
| Return on Invested Capital | 10.69% |
| Profit Margin (Quarterly) | 15.48% |
| Operating Margin (Quarterly) | 17.48% |
| Return on Net Operating Assets | 10.01% |